Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 511 AL 525

The role of microRNA-34 family in Alzheimer's disease: A potential molecular link between neurodegeneration and metabolic disorders

Bazrgar M, Khodabakhsh P, Prudencio M, Mohagheghi F, Ahmadiani A.

Pharmacol Res. 2021 Oct;172:105805. doi: 10.1016/j.phrs.2021.105805. Epub 2021 Aug 8.

Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer's disease?

Carbone MG, Pagni G, Tagliarini C, Imbimbo BP, Pomara N.

Ageing Res Rev. 2021 Nov;71:101420. doi: 10.1016/j.arr.2021.101420. Epub 2021 Aug 8.

Untangling huge literature to disinter genetic underpinnings of Alzheimer's Disease: A systematic review and meta-analysis

G N S HS, Marise VLP, Satish KS, Yergolkar AV, Krishnamurthy M, Ganesan Rajalekshmi S, Radhika K, Burri RR.

Ageing Res Rev. 2021 Nov;71:101421. doi: 10.1016/j.arr.2021.101421. Epub 2021 Aug 8.

Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research

Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, Wang Y, Li J, Yao Y.

Transl Neurodegener. 2021 Aug 9;10(1):27. doi: 10.1186/s40035-021-00252-3.

Lipids on the pathomechanisms of amyloid diseases

Ramamoorthy A.

Chem Phys Lipids. 2021 Sep;239:105122. doi: 10.1016/j.chemphyslip.2021.105122. Epub 2021 Aug 8.

Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products

Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU.

Mediators Inflamm. 2021 Jul 31;2021:9982954. doi: 10.1155/2021/9982954. eCollection 2021.

Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease

Bai H, Zhang Q.

Front Immunol. 2021 Jul 26;12:701282. doi: 10.3389/fimmu.2021.701282. eCollection 2021.

The neurobiology of non-coding RNAs and Alzheimer's disease pathogenesis: Pathways, mechanisms and translational opportunities

Lauretti E, Dabrowski K, Praticò D.

Ageing Res Rev. 2021 Nov;71:101425. doi: 10.1016/j.arr.2021.101425. Epub 2021 Aug 9.

Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential

Sharma VK, Singh TG, Singh S, Garg N, Dhiman S.

Neurochem Res. 2021 Dec;46(12):3103-3122. doi: 10.1007/s11064-021-03418-7. Epub 2021 Aug 12.

The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?

Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D.

Cell Stress Chaperones. 2021 Nov;26(6):871-887. doi: 10.1007/s12192-021-01231-3. Epub 2021 Aug 13.

Degenerative dementias: Alterations of emotions and mood disorders

Mendez MF.

Handb Clin Neurol. 2021;183:261-281. doi: 10.1016/B978-0-12-822290-4.00012-8.

Resurgence of phosphotyrosine binding domains: Structural and functional properties essential for understanding disease pathogenesis

Padarti A, Abou-Fadel J, Zhang J.

Biochim Biophys Acta Gen Subj. 2021 Nov;1865(11):129977. doi: 10.1016/j.bbagen.2021.129977. Epub 2021 Aug 12.

The microglial lysosomal system in Alzheimer's disease: Guardian against proteinopathy

Van Acker ZP, Perdok A, Bretou M, Annaert W.

Ageing Res Rev. 2021 Nov;71:101444. doi: 10.1016/j.arr.2021.101444. Epub 2021 Aug 12.

Cortical Circuitry and Synaptic Dysfunctions in Alzheimer's Disease and Other Dementias

Ranieri F, Benussi A, Cantone M, Ferreri F, Márquez-Ruiz J.

Neural Plast. 2021 Jul 29;2021:9796576. doi: 10.1155/2021/9796576. eCollection 2021.

Revisiting Apathy in Alzheimer's Disease: From Conceptualization to Therapeutic Approaches

Teixeira AL, Gonzales MM, de Souza LC, Weisenbach SL.

Behav Neurol. 2021 Aug 3;2021:6319826. doi: 10.1155/2021/6319826. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias